Hedge Fund News: Jim Chanos, Thomas Steyer & Carl Icahn
Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Highland Capital Management James Dondero | 0 | $0 | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.46 | 2,490,517 | $1,145,637.82 | 0 | 2025-01-14 | Filing | |
$0.42 | 2,000,000 | $840,000.00 | 2,490,517 | 2025-01-13 | Filing | |
$0.46 | 2,500,000 | $1,150,000.00 | 4,490,517 | 2025-01-10 | Filing | |
$0.47 | 1,645,916 | $773,580.52 | 6,990,517 | 2025-01-08 | Filing | |
$0.46 | 521,788 | $240,022.48 | 0 | 2025-01-08 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 13,763.283,333,333 | $86,378 | 0.01% | |
2. | 7,730 | $48,513 | 0% | |
3. | 3,862.3,333,333,333 | $24,240 | 0% | |
4. | 1,210.5,833,333,333 | $7,627 | 0% | |
5. | 1,158.95 | $7,274 | 0% |